Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 03.10.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
03.10.23Greggs - FY23 profit expectations reiterated313Greggs continues to generate premium sales growth through a combination of volume, including market share gains as distribution increases, and price growth. The strength of underlying trading in Q323...
► Artikel lesen
03.10.23IP Group - Detailed look at the deeptech portfolio391IP Group has built a commendable portfolio of businesses developing breakthrough technologies, with an aggregate value of more than £200m at end-June 2023 (c 16% of IP Group's total portfolio value)...
► Artikel lesen
03.10.23UIL - Investing for long-term value creation209UIL Limited's (UIL's) value-focused manager, Charles Jillings, is supported by a seasoned global team of sector specialists. The company has experienced a difficult spell of relative performance during...
► Artikel lesen
03.10.23OSE Immunotherapeutics - Maintaining momentum after an active H123320OSE Immunotherapeutics (OSE) has announced its H123 results, providing an operational and a financial update. Highlights from the period included positive recommendations for a confirmatory pivotal...
► Artikel lesen
03.10.23Basilea Pharmaceutica - FDA accepts New Drug Application for ceftobiprole314Basilea has announced that the US FDA has accepted its New Drug Application (NDA) for ceftobiprole. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date of 3 April 2024, meaning that Basilea...
► Artikel lesen